$Alibaba(BABA)$ Selling call options can seem like a straightforward way to generate income, especially when you own the underlying stock. However, my recent experience with Alibaba (BABA) has taught me that this strategy comes with significant risks, particularly when the market moves against you. Here’s my story and a cautionary tale about the dangers of selling call options. I held 300 shares of Alibaba, which I had purchased at $130 per share. Feeling confident about my position, I decided to sell 3 call option contracts with a strike price of $135, receiving a premium of $3 per share. At the time, this seemed like a great idea. I had an $8 buffer ($135 strike price minus my $130 purchase price plus the $
1. $Palantir Technologies Inc.(PLTR)$ PLTR looked like it found a bottom yesterday… then Jim Cramer tweeted 😂Today’s bounce completely failed, and now the question is...where does PLTR go from here?2. $SPDR S&P 500 ETF Trust(SPY)$ SPY is dropping again, and this next level is criticalWe’re approaching a major support at $570, and in tonight’s video I break down why this could be a make-or-break moment. I’ll cover whether price is about to break structure, why a rebound could still be on the table, and how I’m protecting my portfolio heading into 2025.3. $Tesla Motors(TSLA)$ TSLA Drops Another 5% 📉 Is the Bottom Actually In?Yesterday, it looked like we might ha
1. $Amazon.com(AMZN)$ AMZN is at a massive discount, but was yesterday’s bounce a trap?We saw signs of higher lows yesterday, but today’s sell-off raises questions. 2. $Alphabet(GOOG)$$Alphabet(GOOGL)$ GOOG has been selling off hard, but something just changedFor three straight days, the BX Trender has made higher lows and buyers are stepping in while the rest of the market struggles.3. $Strategy(MSTR)$ MSTR is approaching one of the most critical closes in monthsIf the BX Trender confirms this Friday, this could mark the bottom. A breakout to $450 in the next 3-6 months is on the table.4.
💰Stocks that bring both profit and interest in Healthcare Industry: AMGN/ABBV/JNJ
💰 Winning in chaos requires strong fundamentals!💹 $Amgen(AMGN)$/$AbbVie(ABBV)$/$Johnson & Johnson(JNJ)$: Here are the outperformers, who also offer astonishing dividend yields.📣 Stay tuned and supercharge purchasing power with CashBoost!America is back!In a prominent position on the White House official website, a carefully designed portrait of President Trump occupies the core area of the homepage, and the bold font "AMERICA IS BACK" creates a strong visual impact.On March 4, President Trump began his speech to the joint session of Congress with "America is back!" During the speech, the venue presented a clear bipartisan divide. Republicans frequently applaud
Petrobras Earning Loses Steam Alongside Its Dividend?
$Petroleo Brasileiro SA Petrobras(PBR)$ Petrobras Update Good day, fellow Tiger. Petrobras has been riding roller coaster, though its performance hasn't been stellar lately. Looking at the stock from a long-term perspective, we've seen cycles of booms and busts driven by oil prices. Currently, Petrobras finds itself in a mid-range position, slightly weaker over the past five years and in recent periods. However, the key highlight is its dividend yield of 16%, P/E ratio of 11.55, and market cap of $48 billion. Let’s examine Petrobras' newly released strategic plan to see where the company is headed. A Unique Approach Compared to Wall Street One notable aspect of Petrobras’ strategy is how openly it acknowledges the long-term decline in oil demand. T
The eye of the storm; Don’t be alarmed it gets much worse.
Trump’s Tariffs: Inflation Fears and Yield Pressure Donald Trump’s recent tariff moves—25% on imports from Canada and Mexico, plus an additional 10% on Chinese goods—have jolted global markets. Tariffs of this magnitude, targeting major U.S. trading partners, threaten to disrupt supply chains and raise the cost of imported goods. Economists estimate that a 10% tariff could shave 0.3% off eurozone growth annually unless offset by currency depreciation, while a 20% tariff might halve the region’s projected 1% growth for 2025. In the U.S., the impact could be a GDP drop of 1.3–1.5% in the first two years, though a stronger trade balance might mitigate this over time. The immediate concern for bond markets is inflation. Higher import costs could fuel price pressures, reducing the Federal Reser
Salesforce Beats Earning but Forecasts Slower Growth
$Salesforce.com(CRM)$ Salesforce remains a dominant player in the CRM market, fueled by its expanding AI and Data Cloud capabilities. The company has demonstrated impressive growth, with its Data Cloud and AI annual recurring revenue reaching $900 million—marking a 120% year-over-year increase. Agentforce, a key AI-powered customer service tool, has gained strong traction, securing 5,000 deals since October, with over 3,000 being paid. Meanwhile, Data Cloud continues to scale rapidly, exceeding 50 trillion records—doubling year-over-year. Nearly half of the Fortune 100 companies now utilize both AI and Data Cloud, and all of Salesforce’s top 10 deals in Q4 incorporated AI and Data integration. Earning Overview In Q4 2025, Salesforce reported $10 bi
$Vaxcyte, Inc.(PCVX)$$Madrigal Pharmaceuticals(MDGL)$ 💉💊📈🅱️ U͎ L͎ L͎ I͎ S͎ H͎💊💉 🚀 Biotech’s Big Bet, Vaxcyte ($PCVX), Madrigal ($MDGL) & 2025’s Healthcare Boom Markets are a pressure cooker in March 2025, with 10-year Treasury yields creeping toward 4.2%, PMI data flashing manufacturing weakness, and tariff threats rattling equities. Yet, Goldman Sachs’ David Kostin is doubling down on healthcare, a sector that has outperformed the S&P 500 by 7 points YTD while still trading at an 18% P/E discount, the widest in 20 years. With healthcare powering 17% of US GDP, it is the perfect defensive, offensive hybrid. That is why I am zooming in on two biotech powerhouses backed by Goldman Sachs. ✅ Vaxcyte
Nio (NIO) Return On Investment And Vehicle Sales TO Watch
$NIO Inc.(NIO)$ is expected to release their Q4 2024 quarterly result for period ending 31 December 2024 on 11 March 2025 (to be confirmed). Market expect NIO to show a rise in quarterly revenue of 17.9% increase in revenue to CNY20.163 billion from CNY17.1 billion a year ago. This is inline with the guidance given by NIO on 20 Nov 2024 which has the revenue between CNY19.68 billion and CNY20.38 billion. The earnings consensus estimate is expected to come in at a loss of CNY2.44 per share or 34 cents. Nio (NIO) Last Neutral Earnings Call Saw Share Price Decline By 8.42% NIO had a neutral earnings call on 20 Nov 2024 which saw the share price decline by 8.42% since. The earnings call highlighted strong vehicle delivery performance, positive cash flo
$Global X Defense Tech ETF(SHLD)$ has just recently hit its 52 week high at USD 47.00 as Defence spending by central governments especially the US, have boosted their military spending. The Top 10 holdings include $Palantir Technologies Inc.(PLTR)$ Rheinmetall AG, $RTX Corp(RTX)$ $Northrop Grumman(NOC)$ Thales SA and many more. The expense ratio is 0.50%. Dividends are paid every 6 months. The current dividend yield is 0.69%. With geopolitical conflicts especially in the Middle East and Ukraine still ongoing,
Analyzing Broadcom (AVGO) Stock: Opportunities and Challenges Amid Market Volatility
As of March 6, 2025, Broadcom (AVGO), a leading semiconductor and networking equipment giant, has experienced a rollercoaster day on the stock market, offering both opportunities and challenges for investors. With a post-market trading price of $179.45 after a 6.33% drop during regular trading, followed by a striking 10.54% rebound, the stock’s volatility reflects a mix of macroeconomic pressures and company-specific developments. Let’s break it down. Market Performance and Technical Insights The day’s regular trading saw AVGO decline by $12.13, closing at $179.45, influenced by broader market concerns, including potential tariffs under the Trump administration and a lackluster performance from rival Marvell Technology. However, the post-market surge of $18.91 was triggered by Broadc
Market Overview Global markets showed mixed performances as US stocks extended their sharp pullback despite concessions on tariffs, while European and Asian markets found relief from positive policy signals and tariff delays. Uncertainty around US trade policies and investor sentiment continues to drive volatility across major indices. US: Steep Decline Continues Amid Trade Uncertainty US markets fell sharply as investor concerns over President Donald Trump's controversial tariff policies persisted. Despite White House concessions, the Dow Jones $DJIA(.DJI)$ dropped 427.51 points (-0.9%) to 42,579.08, while the S&P 500 $S&P 500(.SPX)$
<
$Oracle(ORCL)$ will be reporting its quarterly earnings result for period for fiscal Q3 2025 on 10 March 2025 after market close. ORCL is expected to post an earnings per share at $1.49 per share, this would represent an increase of 5% compared to same period one year ago. Revenues is forecast to come in at $14.36 billion, representing an increase of 8.1% year over year. Oracle (ORCL) Last Positive Earnings Call Saw A Decline Of 20.55% ORCL had a positive earnings call on 09 Dec 2024 but the share price saw a decline of 20.55% since then. The earnings call highlighted strong growth in cloud revenue, particularly in AI demand and infrastructure, and a significant increase in remaining performance obligations, indicating robust future revenue. Howev
$S&P 500(.SPX)$ has reached the 200-day moving average (DMA) amidst extreme fear, a level not seen since the 10% correction in October 2023. The Bollinger Bands are widening and the lower one looks like a slider ➡️The hope for a bounce is in the pink line and its confluence with $5739, a level shared last Friday. Any bounce has to recover $5812, the level that rejected the bounce today.Imagehis is from a previous year, if you remember this chart, it means you survived 2022 and you didn't throw the towel and continued trading/investing. ➡️Where are we? A or B?Image
In the age of the “everything bubble”, it’s not often that you come across a chart saying something is outright cheap, or even near-record lows for that matter…And I know what you might be thinking — “it’s cheap for a reason“ or “it’s a value trap“ or maybe even “valuations don’t matter“.And there are situations where either or all 3 of those claims can genuinely apply.For example, “cheap for a reason“ is almost always true, because most of the time when an asset or market is cheap it’s because of a cyclical deterioration in fundamentals, or some kind of shock/crisis, or some other logical reason. A lot of the time that deterioration is transitory, and markets often overreact to that deterioration — driving valuations down further than they really should be (aka opportunities).Meanwhile “i
Democratizing “Rich People Sh*t” As a Business Model
Making stuff for rich people accessible to the masses hasn’t often been an explicit part of the business model for companies. But I’m hearing it more and more.It was this interview with Vlad Tenev from $Robinhood(HOOD)$ that piqued my interest in the company and ultimately drove me to add Robinhood to the Asymmetric Portfolio last year. He said in part:The idea behind Robinhood Gold is, if you’re a high net worth individual and you’re accustomed to a level of service from your bank or financial institution, we want to open up that private client, high net worth experience for just $5 per month to the mass market.Vlad Tenev, Robinhood CEOTaken with that lens, Robinhood’s strategy of adding more services to Gold and leveraging its lower cost structu
BTCUSD - Bull ExtensionBTCUSD: BTCUSD - Bull Extension Price right now has relatively been contained within an upward channel In this chart i suggest a breakout of this trend line / channel and extension up to create a new ATH for this bull run I have used the bars pattern from the 2016 - 17 run Lets see what happens. Daily chartBTCUSD - Similar ChannelsBTCUSD: BTCUSD - Similar Channels Current channel can be contrasted to the previous 2017 run We are at the stage before aggressive bulls take control pushing above this channel The verge of a large breakout for crypto across the board I don't know if price will surpass 1m but it
Wall Street Floor Large Orders: NVIDIA Year-End Lowest Expectation at 146
$NVIDIA(NVDA)$ The "2 Billion" trader rolled over their April 120 call to June 120 call $NVDA 20250620 120.0 CALL$ .The strike price remains unchanged, and the transaction volume is consistent, suggesting that the Q2 market is expected to mirror Q1.On Wednesday, open interest rankings saw significant changes. For call options: $NVDA 20250620 120.0 CALL$ added 100,000 contracts, ranking fourth; weekly expiration 120 calls saw a surge in opening volume; 130 calls closed over 15,000 contracts.Regarding put options: March monthly 120 puts rolled over into recent bearish positions. June expiration 90 puts added 30
The Mild Rise. On Wed, 05 Mar 2025, $BigBear.ai Holdings(BBAI)$ shares fell as much as -3.0% intraday. Thankfully, by the time 4pm came around, it closed higher at +1.91%, ahead of the company’s Q4 quarter earnings that will be released after the closing bell on Thursday. (see below) BBAI has been trending downwards since news broke that the Trump administration directed the Department of Defense (DOD) to cut $50 billion in spending. This worked out to be about 6% of the total defense budget and in the process, dampened retail sentiment. The move raises concerns for defense contractors like BBAI, that relies heavily on government contracts. Quarterly Earnings - Past & Forecast. The AI solutions provider has struggled with profitability, postin